Memorial Sloan Kettering Cancer Center: Neoplasms, Germ Cell and Embryonal trials

The registry lists 17 Neoplasms, Germ Cell and Embryonal studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 1 are open to participants now and 5 have results posted.

Phase 1 3Phase 2 13Phase 3 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Germ Cell Tumor and Testicular Tumor DNA RegistryRecruitingNCT02099734
• Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell TumorsCompletedNCT00470366Phase 2Results posted
• Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to TreatmentCompletedNCT00453310Phase 2Results posted
• Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to CisplatinCompletedNCT00423852Phase 1/2Results posted
• Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid TumorsCompletedNCT00024258Phase 2Results posted
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell TumorsCompletedNCT00002558Phase 1/2Results posted
• Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell TumorsActive, not recruitingNCT03158064Phase 2
• Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell TumorsActive, not recruitingNCT01873326Phase 2
• Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor ControlsActive, not recruitingNCT01453660
• Genomic Structural Variation in Cancer SusceptibilityActive, not recruitingNCT00996710
• Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell TumorsCompletedNCT00070096Phase 2
• Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to CisplatinCompletedNCT00006043Phase 2
• High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid TumorsCompletedNCT00003173Phase 2
• Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell TumorsCompletedNCT00002596Phase 3
• Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous CisplatinCompletedNCT00002559Phase 1/2
• Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare CancerCompletedNCT00002515Phase 2
• Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell TumorsCompletedNCT00002489Phase 2